Share

April 29, 2014; 82 (17) Clinical/Scientific Notes

Rheumatoid meningitis presenting with stroke-like episodes

Pascale Bourgeois, Jean Rivest, Christian Bocti
First published March 19, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000366
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1611

Share

Article Information

vol. 82 no. 17 1564-1565
DOI: 
https://doi.org/10.1212/WNL.0000000000000366
PubMed: 
24647026
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 30, 2013
  • Accepted in final form January 21, 2014
  • First Published March 19, 2014.

Article Versions

Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Pascale Bourgeois, MD,
    2. Jean Rivest, MD, FRCPC and
    3. Christian Bocti, MD, FRCPC
  1. Pascale Bourgeois, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jean Rivest, MD, FRCPC and
    3. Scientific Advisory Boards:

    1. merz advisory board, december 2013,miami commercial

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. speaker honoraria, commercial ( Allergan, Merz )

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. ongoing clinical study sponsored by Allergan

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Christian Bocti, MD, FRCPC
    4. Scientific Advisory Boards:

    1. Merck, Novartis

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Speaker honoraria from Novartis, Merck, Pfizer.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. Canadian Institutes for Health Research (CIHR) co-applicant; #246677, 2012-2016; #272996, 2013-2017. Fonds de la rechercher en sant� du Qu�bec, Clinician-Scientist Salary Award, 2012

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From CHUS, Sherbrooke, Québec, Canada.
  1. Correspondence to Dr. Bourgeois: pascale.bourgeois{at}usherbrooke.ca
View Full Text

Article usage

Article usage: March 2014 to May 2022

AbstractFullPdfSource
Mar 201483020Highwire
Apr 20146533147Highwire
May 201411021935Highwire
Jun 201426968Highwire
Jul 2014262715Highwire
Aug 201419437Highwire
Sep 201424675Highwire
Oct 201425532Highwire
Nov 201426742Highwire
Dec 201421130Highwire
Jan 201518113Highwire
Jan 201502414pmc
Feb 201517600Highwire
Feb 201503221pmc
Mar 201523222Highwire
Mar 201504121pmc
Apr 201528710Highwire
Apr 201503618pmc
May 201514843Highwire
May 201504020pmc
Jun 201517034Highwire
Jun 201503918pmc
Jul 201516920Highwire
Jul 20150639pmc
Aug 201514364Highwire
Aug 201504719pmc
Sep 201518921Highwire
Sep 201506942pmc
Oct 201517410Highwire
Oct 201505115pmc
Nov 201518512Highwire
Nov 201504023pmc
Dec 20159112Highwire
Dec 201504817pmc
Jan 20169800Highwire
Jan 20160254pmc
Feb 201619800Highwire
Feb 201606630pmc
Mar 201621412Highwire
Mar 201604225pmc
Apr 201617021Highwire
Apr 201604515pmc
May 201613012Highwire
May 201605015pmc
Jun 20169843Highwire
Jun 201603814pmc
Jul 20167512Highwire
Jul 20160398pmc
Aug 20167824Highwire
Aug 20160508pmc
Sep 201613710Highwire
Sep 201605313pmc
Oct 201614710Highwire
Oct 201607022pmc
Nov 201619034Highwire
Nov 201606312pmc
Dec 201611700Highwire
Dec 201608616pmc
Jan 201710910Highwire
Jan 20170637pmc
Feb 201717800Highwire
Feb 201709728pmc
Mar 201717451Highwire
Mar 201701037pmc
Apr 201713211Highwire
Apr 2017127083pmc
May 201715000Highwire
May 2017115761pmc
Jun 20176710Highwire
Jun 201795664pmc
Jul 20177600Highwire
Jul 2017148395pmc
Aug 20177900Highwire
Aug 201767487pmc
Sep 20178543Highwire
Sep 2017125973pmc
Oct 201714701Highwire
Oct 20179100107pmc
Nov 201714024Highwire
Nov 2017107075pmc
Dec 20171100Highwire
Jan 20183122Highwire
Feb 20181310Highwire
Mar 20182271Highwire
Apr 20181600Highwire
Apr 20181181104pmc
May 20182231Highwire
Jun 20181500Highwire
Jun 20181594102pmc
Jul 20181700Highwire
Aug 20182201Highwire
Aug 2018228187pmc
Sep 20182011Highwire
Oct 20182511Highwire
Nov 20182031Highwire
Dec 20183531Highwire
Jan 20191920Highwire
Feb 20192600Highwire
Mar 20191000Highwire
Apr 20191310Highwire
May 2019900Highwire
Jun 2019500Highwire
Jul 2019331Highwire
Aug 20191201Highwire
Sep 2019811Highwire
Oct 20192710Highwire
Nov 20191701Highwire
Dec 20191100Highwire
Jan 20201521Highwire
Feb 2020900Highwire
Mar 20201001Highwire
Apr 20201001Highwire
May 20202200Highwire
Jun 20201000Highwire
Jul 2020500Highwire
Aug 2020710Highwire
Sep 20201221Highwire
Oct 20201010Highwire
Nov 2020842Highwire
Dec 20201000Highwire
Jan 20212510Highwire
Feb 20211910Highwire
Mar 20211900Highwire
Apr 20211220Highwire
May 20215000Highwire
Jun 2021620Highwire
Jul 20212910Highwire
Aug 20211610Highwire
Sep 20211360Highwire
Oct 20211400Highwire
Nov 20211111Highwire
Dec 2021800Highwire
Jan 20221500Highwire
Feb 20221211Highwire
Mar 20222131Highwire
Apr 20221020Highwire
May 20222700Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me